Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain

NCT02000401 ↗

Phase 4 Completed 15 enrolled Citrus Valley Medical Research, Inc.

NaSingle-groupOpen-labelTreatment

Summary

Intranasal Ketorolac tromethamine has a potential role as a short term pain management tool for Interstitial Cystitis without the risk and undesirable effects of narcotics.

Timeline

Start: 2012-05
Primary completion: 2013-07
Completion: 2013-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ketorolac Tromethamine	Small molecule	31.5 mg	Intranasal

Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain

Summary

Timeline

Drugs

Indications